エムビジョンヘルス(MVision health)は、脳ドックのMRI撮影画像データから、高精度のAI(人工知能)によって全脳505構造を解析します。そして、認知症進行の指標である脳の萎縮・白質病変を、3万件以上のビッグデータと比較の上、人間の目には見えないものまで含めて評価できます。株式会社エムでは、商用目的のライセンス利用許諾を受け、独占的に日本の医療機関様にご提供しています。
Investors 1
Mentions in press and media 4
| Date | Title | Description |
| 23.12.2025 | Bridging the "Last Mile" of Medical Innovation: ICMIS 2025 Successfully Concludes with Capital and Industry Collaborating to Accelerate Commercialization | HONG KONG, Dec. 23, 2025 /PRNewswire/ -- In the current global MedTech landscape, technological breakthroughs are only the starting point. The real measure of scientific research is whether laboratory discoveries can be translated into safe... |
| 17.09.2024 | M Co., Ltd. Raised funds through Series A first close, reaching a cumulative total of 500 million yen | [M Co., Ltd.] Raised funds through Series A first close, reaching a cumulative total of 500 million yen
*M Co., Ltd.*
Press release: September 17, 2024
**
[M Co., Ltd.] Raised funds through Series A first close, reaching a cumulative total ... |
| 31.05.2024 | Start of business co-creation with large companies – 1st period of global business co-creation program “AgeTechX” A total of 11 companies were selected, including 3 overseas startups, and business co-... | - |
| 31.05.2024 | Start of business co-creation with large companies – 1st period of global business co-creation program “AgeTechX” A total of 11 companies were selected, including 3 overseas startups, and business co-... | Start of business co-creation with large companies – 1st term of global business co-creation program “AgeTechX”
A total of 11 companies were selected, including three overseas startups, and business co-creation began with new participants O... |
Reviews 0